• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[奈达铂和伊立替康新辅助化疗后侵袭膈肌的肺鳞状细胞癌完全切除1例]

[A case of complete resection of a squamous cell lung cancer invading diaphragm after neoadjuvant chemotherapy of nedaplatin and irinotecan].

作者信息

Yutaka Yojiro, Omasa Mitsugu, Matsumoto Masataka, Ueda Yuichiro, Tomiyama Kenichi, Shikuma Kei, Fukui Motonari, Taki Toshihiko

机构信息

Dept. of Thoracic Surgery, Ohtsu Red-Cross Hospital.

出版信息

Gan To Kagaku Ryoho. 2010 Nov;37(11):2151-3.

PMID:21084816
Abstract

The treatment for squamous cell lung cancer has remained unclear, while that for lung cancer according to each pathology type has advanced. This is a case of complete response of a squamous cell lung cancer invading the diaphragm which could be resected completely after neoadjuvant chemotherapy of nedaplatin (CDGP) and irinotecan (CPT-11). CDGP and CPT-11 might be effective for squamous cell lung cancer.

摘要

鳞状细胞肺癌的治疗方法仍不明确，而根据每种病理类型的肺癌治疗方法已经取得了进展。这是一例侵犯膈肌的鳞状细胞肺癌病例，在接受奈达铂（CDGP）和伊立替康（CPT-11）新辅助化疗后可完全切除，实现了完全缓解。CDGP和CPT-11可能对鳞状细胞肺癌有效。

相似文献

1
[A case of complete resection of a squamous cell lung cancer invading diaphragm after neoadjuvant chemotherapy of nedaplatin and irinotecan].[奈达铂和伊立替康新辅助化疗后侵袭膈肌的肺鳞状细胞癌完全切除1例]
Gan To Kagaku Ryoho. 2010 Nov;37(11):2151-3.
2
Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910.奈达铂与伊立替康治疗肺鳞状细胞癌患者的多中心II期研究：胸部肿瘤学研究组0910
Anticancer Res. 2015 Dec;35(12):6705-11.
3
Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials.比较奈达铂和顺铂治疗非小细胞肺癌的疗效和安全性的 Meta 分析。
J Thorac Oncol. 2011 Jan;6(1):128-31. doi: 10.1097/JTO.0b013e3181ccb3a9.
4
Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.伊立替康（CPT-11）与奈达铂新辅助化疗后行根治性子宫切除术治疗局部晚期宫颈癌的临床疗效
J Int Med Res. 2016 Apr;44(2):346-56. doi: 10.1177/0300060515591858. Epub 2016 Feb 1.
5
Feasible combination chemotherapy with nedaplatin and irinotecan for patients with non-small cell lung cancer and multiple high-risk factors.
J Exp Ther Oncol. 2007;6(3):251-6.
6
Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.奈达铂递增剂量联合伊立替康治疗晚期非小细胞肺癌的I/II期研究
Cancer Chemother Pharmacol. 2003 Jul;52(1):73-8. doi: 10.1007/s00280-003-0615-y. Epub 2003 May 16.
7
Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.盐酸伊立替康与奈达铂联合新化疗方案对人宫颈癌细胞系的抗肿瘤活性
Oncol Rep. 2003 May-Jun;10(3):593-8.
8
Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer.
J Exp Ther Oncol. 2004 Dec;4(4):343-8.
9
[A case of elderly advanced squamous cell lung carcinoma successfully treated with nedaplatin and S-1 combination chemotherapy].[奈达铂与S-1联合化疗成功治疗老年晚期肺鳞状细胞癌1例]
Gan To Kagaku Ryoho. 2012 Mar;39(3):429-32.
10
[Collision cancer of squamous cell carcinoma and small cell carcinoma of the lung; report of a case].[肺鳞状细胞癌与小细胞癌碰撞癌；1例报告]
Kyobu Geka. 2006 Jun;59(6):497-500.